Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is... see more

CSE:RVV - Post Discussion

Revive Therapeutics Ltd > The Doctors opinion
View:
Post by ultimtvitality on Aug 21, 2020 4:05pm

The Doctors opinion

I just had a 45 minute call with a integrative medicine doc with over 30 years of experience. We went of the technical aspect of N-acetyl cysteine and looked at bucillamine. Bucillamine would theoretically inactivate hydrogen peroxide  and convert it to water much more efficiently because it has 2 Thiol donor groups that convert to glutathione  So 16x more potent. Glutathione is the potent antioxidant that can mitigate the inflammatory response caused by the virus . With well established clinical applications of NAC in respiratory conditions and the potential mitigation of cytokine storm caused by COVID Bucillamine looks very good with regard to its application for mild to moderate COVID. In addition it has very good indications for anotther application in organ perfusion injury IE Myocaridal infarction. It would essentialy protect damaged cells when the mitochondria are starved of oxygen. This could be what patients take on the way to the hospital in an ambulance for MI in the future. I am gaining confidence that the results of this trial will be positive.
Comment by Trippedstocks on Aug 21, 2020 5:01pm
thanks for the info, but we all new that already. Anyone who didn't do DD on Bucillamine shouldn't be here. Yep, influenza, heart, lungs, organ transplant, thiol donor for this intended use. It's a chelating agent when used for RA. And in some cases can cause BOOP after chronic use. Here's a new one... As of June the US Army biological/chemical threat advisors had not heard of ...more  
Comment by ezemoney on Aug 21, 2020 5:30pm
And I would add if you are in icu and on a ventilator seeing angels floating above your head, a dose of psilocybin would be a very nice add on.
Comment by ultimtvitality on Aug 21, 2020 5:51pm
Yes psychedelics helps thin the veil to the connection with the unified field of consciousness helps us understand we are all connected and one . I love the science of psychedelics. One of my favorite topics. It is plant medicine.
Comment by ultimtvitality on Aug 21, 2020 5:47pm
I have done DD but I wanted to share info with the group that I met with a top integrative medicine doc from San Francisco with over 30 years of experience. Since this is related to NAC he was gracious enough to look at it from his perspective and it was nice to have some support on the science of this and potential success of the compound long and short term. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse